athx stock reddit

EIA reports U.S. distillate stockpiles decline by 2.3 million barrels ATHX | Complete Athersys Inc. stock news by MarketWatch.

The biopharmaceutical company can be reached via phone at 216-431-9900 or via email at Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Top institutional shareholders include Coastal Investment Advisors Inc. (0.44%), GW&K Investment Management LLC (0.29%), Swiss National Bank (0.21%), California Public Employees Retirement System (0.20%), M&G Investment Management Ltd. (0.11%) and Cedar Brook Financial Partners LLC (0.10%).

Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis.

Copyright © 2020 MarketWatch, Inc. All rights reserved. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. A famous miner could have a huge new mine miles from nowhere.Athersys has received a consensus rating of Buy.

Athersys, Inc. By using this site you agree to the EIA reports U.S. gasoline supplies down 700,000 barrels

Since then, ATHX shares have increased by 78.1% and is now trading at $2.28. Share your opinion and gain insight from other stock traders and investors. On Reddit/Athx 3 reports that Healios announced a filing for a license to sell MS for pneumonia induced ARDS expected to be granted 1Q, 2021 with sales by the Summer of 2021. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.Athersys' management team includes the following people: Co-Founder, Chief Scientific Officer, Exec.

share.

There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Close. September WTI crude trades at $42.56/bbl on Nymex, up 95 cents, or 2.3% EIA reports U.S. distillate stockpiles decline by 2.3 million barrels

Message board - Online Community of active, educated investors researching and discussing Athersys, Inc. Stocks.

"Athersys' stock is owned by a variety of retail and institutional investors.

17. Abstract. 7 comments.

Posted by 2 months ago.

The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. Athersys, Inc. ATHX 2.62 0.02 (0.77%). The company has license and collaboration agreements with Healios K.K. The biopharmaceutical company earns $-44,580,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis. By using this site you agree to the © American Consumer News, LLC dba MarketBeat® 2010-2020. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners.

On Reddit/Athx 3 reports that Healios announced a filing for a license to sell MS for pneumonia induced ARDS expected to be granted 1Q, 2021 with sales by the Summer of 2021. Find the latest Athersys, Inc. (ATHX) stock quote, history, news and other vital information to help you with your stock trading and investing. Sign-up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter.Athersys' stock was trading at $1.28 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO).

Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Shorts playing with fire. One share of ATHX stock can currently be purchased for approximately $2.28.Athersys has a market capitalization of $447.97 million and generates $5.63 million in revenue each year. September WTI crude trades at $42.56/bbl on Nymex, up 95 cents, or 2.3% All rights reserved. Athersys, Inc. (NASDAQ:ATHX) posted its quarterly earnings results on Monday, August, 10th. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas.

Export data to Excel for your own analysis.

Reply Replies (5) 17 1. t. tim. The share price was reported to have risen 15%. 4 analysts have issued 12-month target prices for Athersys' shares. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources.

Athersys, Inc. View real-time stock prices and stock quotes for a full financial overview. This suggests a possible upside of 294.7% from the stock's current price. News and discussion for the company Athersys Inc. Press J to jump to the feed. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable.